Andrew D. RuskinPartnerK&L Gates LLPWebsitewww.klgates.comOrganization ProfileFull ProfileConnectEmailTwitterLinkedIn202-778-9415 Professional Biography Andrew Ruskin is a partner in the firm’s Washington, D.C. office. He is a member of the health care and FDA practice group. Areas of Focus Health Care and FDA Food, Drugs, Medical Devices, and Cosmetics (FDA) More Legal and Business Bylines From Andrew D. Ruskin Rural Emergency Hospitals — Transformative Change or Limited Impact? [PODCAST] - (Posted On Wednesday, March 22, 2023) Recent Developments to the 340B Drug Pricing Program [PODCAST] - (Posted On Thursday, December 15, 2022) New Data Available Under the Hospital Price Transparency Rule [PODCAST] - (Posted On Thursday, November 17, 2022) Genesis Healthcare and the 340B Program Patient Definition [PODCAST] - (Posted On Tuesday, August 09, 2022) Supreme Court Issues Decision Favorable to Hospitals on 340 B Payment Reduction: What to Do Next - (Posted On Tuesday, June 21, 2022) Medicare Reimbursement for Community Hospital Residency Programs [PODCAST] - (Posted On Monday, January 31, 2022) 2022 OPPS Final Rule Overview: CMS Finalizes Policies on 340B, Hospital Price Transparency, and Inpatient-Only List - (Posted On Monday, November 08, 2021) An Update on the CMS Hospital Price Transparency Rule [PODCAST] - (Posted On Thursday, October 21, 2021) CMS Proposes to Increase Penalties for Hospital Price Transparency Noncompliance - (Posted On Thursday, July 22, 2021) 340B Update: Supreme Court Accepts Certiorari in 340B Payment Reduction Case - (Posted On Thursday, July 08, 2021) Pagination Page 1 Next page Next › Current Legal Analysis Detour Ahead: New Approach to Assessing Prior Art Rejections Under § 102(e) by: Benjamin N. Ediger, PhD Hatch-Waxman Litigation Expenses Are Deductible Under Internal Revenue Code § 162(a) by: Intellectual Property Practice Group Court Sides with RICO Complainant Who Received Tainted Medical Marijuana and with FDA on Regulating E-Cigarettes - SCOTUS Today by: Stuart M. Gerson The Clear and Unmistakable Standard for Applying Prosecution Disclaimer by: Sarah Mezini Using International Arbitration to Resolve Retaliatory Tariff Disputes in Global Supply Chains by: Frederick A. Acomb , James L. Woolard CSRD and CSDDD Officially Delayed, With Huge Majority of MEPs in Support by: John Verwey , Rachel E. Lowe Tempus Fugit Ad Nevada by: Keith Paul Bishop President Trump Announces "Reciprocal" Tariffs Beginning 5 April 2025 by: Nathaniel B. Bolin , David R. Allman Supreme Court Rules Lost Wages May Be Recoverable Under RICO For False Advertising After Drug Test Dismissal by: Bruce J. Douglas , Maria B. Shatonova Wyoming Bans Most Non-Compete Agreements by: Steven J Pearlman , Sehreen Ladak USCIS Announces Initial FY 2026 H-1B Cap Selection: What Employers Need to Do Next by: Jessica K. Lang SEC Provides Further Clarity in Rule 506(c) Offerings by: Daniel I. DeWolf , Samuel Asher Effron FedRAMP 20x – Major Overhaul Announced to Streamline the Security Authorization Process for Government Cloud Offerings by: Townsend L. Bourne , Daniel J. Alvarado USDA Will Fund 543 Projects in 29 States Through Higher Blends Infrastructure Incentive Program by: Lynn L. Bergeson , Carla N. Hutton Immigration Enforcement and Healthcare Facilities: Key Considerations for Providers by: Lotan Barbaresso , Amy J. Dilcher Upcoming Events Apr 30 2025 Workplace Horizons 2025 Apr 3 2025 Defense Counsel: Obligations to Insured Clients and Insurers Apr 3 2025 Defense Counsel: Obligations to Insured Clients and Insurers Apr 7 2025 Understanding the Basics of a Class Action Print
